- Home
- DERM vs DMB Comparison
DERM vs DMB Comparison
Compare DERM & DMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- DMB
- Stock Information
- Founded
- DERM 2014
- DMB 2013
- Country
- DERM United States
- DMB United States
- Employees
- DERM N/A
- DMB N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- DMB Trusts Except Educational Religious and Charitable
- Sector
- DERM Health Care
- DMB Finance
- Exchange
- DERM Nasdaq
- DMB Nasdaq
- Market Cap
- DERM 181.0M
- DMB 181.7M
- IPO Year
- DERM 2021
- DMB N/A
- Fundamental
- Price
- DERM $8.06
- DMB $10.04
- Analyst Decision
- DERM Strong Buy
- DMB
- Analyst Count
- DERM 2
- DMB 0
- Target Price
- DERM $10.00
- DMB N/A
- AVG Volume (30 Days)
- DERM 103.3K
- DMB 76.6K
- Earning Date
- DERM 05-14-2025
- DMB 01-01-0001
- Dividend Yield
- DERM N/A
- DMB 4.17%
- EPS Growth
- DERM N/A
- DMB N/A
- EPS
- DERM N/A
- DMB N/A
- Revenue
- DERM $56,243,000.00
- DMB N/A
- Revenue This Year
- DERM $29.83
- DMB N/A
- Revenue Next Year
- DERM $54.88
- DMB N/A
- P/E Ratio
- DERM N/A
- DMB N/A
- Revenue Growth
- DERM N/A
- DMB N/A
- 52 Week Low
- DERM $3.54
- DMB $8.94
- 52 Week High
- DERM $8.24
- DMB $11.79
- Technical
- Relative Strength Index (RSI)
- DERM 65.90
- DMB 42.07
- Support Level
- DERM $6.55
- DMB $9.97
- Resistance Level
- DERM $7.00
- DMB $10.12
- Average True Range (ATR)
- DERM 0.63
- DMB 0.10
- MACD
- DERM 0.13
- DMB -0.01
- Stochastic Oscillator
- DERM 92.41
- DMB 16.28
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About DMB BNY Mellon Municipal Bond Infrastructure Fund Inc.
BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a diversified closed-end management investment company. The fund's investment objective is to provide as high a current income exempt from regular federal income tax as is consistent with the preservation of capital. It invests in transportation, energy and utilities, social infrastructure, and water and environmental sectors.